Deep Biologics
Toronto
About Deep Biologics
Deep Biologics utilizes AI-based methods to resolve the bottlenecks in developing specific and efficacious biologics for therapeutic and diagnostic purposes. We combine cutting edge in silico technologies with conventional screening, to deliver unprecedented depth, quality, and speed for your biologics discovery pipelines.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $300.0K
- Funding stage: Seed
- Last round: Grant (Jun 2020)
- Website: deepbiologics.ai
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/deep-biologics-219008 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.